1Tallman MS. Curative strategies in acute Promyelocytic leukemia. Washington DC: Hematology 2003 American Society of Hematology Education Program Book,2003.90-101
2Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Seminars in Hematology,2001, 38(1):13
3Wong ZY. Treatment of acute leukemia by inducing differentiation and apotoptosis. Washington DC: Hematology 2003 American Society of Hematology Education Program Book, 2003.1-13
4DouerD. New advances in the treatment of acute promyelocytic leukemia. Int J Hematol, 2003,76(Sppl 2):178
5Avvisati G, Coco FL, Diverio D, et al. AIDA(all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematotogiche Maligne dell Adulto (GIMEMA) Pilot Study. Blood, 1996, 88(4):1390
6Mandelli F, Diverio D, Avvisati G, et al. Molecular remission in Pml/Rar α-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood, 1997,90(3): 1014
7Tallman MS, Andersen JW, Schiffer CA, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.Blood,2000, 95(1):90
8Kenos A, Moine FLE, CrenierL, etal. All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukemia. Br J Haemat, 1997,97(3):685
9Evans G, Grimwade D, Prentice HG, et al. Central nervous system relapse in acute promyelocytic leukemia in patients treated with all-trans retinoic acid. Br J Haemat, 1997, 98(2) :437
10Lazo G, Kantarjian H, Estey E, et al. Use of arsenic trioxide(As2O3) in the treatment of patients with acute promyelocytic leukemia. The MD Anderson Experience Cancer,2003, 97 (9):2218
